+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Pharmacovigilance and Drug Safety Software Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Software Type; Delivery Mode; End User, and Business Process Outsourcing Firms

  • ID: 5359813
  • Report
  • June 2021
  • Region: Europe
  • 132 pages
  • The Insight Partners
UP TO OFF
until Sep 30th 2021

FEATURED COMPANIES

  • AB Cube
  • ArisGlobal LLC
  • Ennov
  • EXTEDO
  • IQVIA Inc.
  • Maxapplication
  • MORE
Adverse Event Reporting Software Segment has the Largest Share of Software Type in the Europe Pharmacovigilance and Drug Safety Software Market during 2020-2027



According to this research study titled “Europe Pharmacovigilance and Drug Safety Software Market to 2027 - COVID-19 Impact and Regional Analysis and Forecast by Software Type, Delivery Mode, and End User,” the market is expected to reach US$ 71.1 million by 2027 from US$ 40.5 million in 2019. The market is estimated to grow at a CAGR of 7.1% from 2020 to 2027. The report provides trends prevailing in the Europe pharmacovigilance and drug safety software market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the rising incidences of adverse drug reaction (ADR) and globalization of pharmacovigilance are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the expensive technology.

Key medical organizations and agencies such as the European Medicines Agency and the UK Medicines and Health Regulatory Agency have provided guidelines for the execution of clinical trials and post-marketing monitoring during the COVID-19 pandemic. While these organizations understand the difficulties involved, patient safety is the focus and still should be performed as normal. The COVID-19 pandemic has caused various regulatory agencies to dramatically revise their standards, and have stressed the value of electronic reporting to ensure patient safety. Having a dedicated safety intelligence team allows an existing communication channel with authorities and the cooperation of local teams facilitates a timely and constructive communication with local authorities to plan alternative measures before it becomes necessary.

The market for pharmacovigilance and drug safety software market is segmented into software type, delivery mode, and end user. In 2019, the adverse event reporting software accounted for the largest market share in the pharmacovigilance and drug safety software market. In pharmacovigilance high volume of adverse reaction report event data generated. These reports may not be in a uniform format which makes it difficult to classify the event manually. Manual processing and classification of adverse event reports is costly and time-consuming operation. To overcome these challenges companies are incorporating automated solutions. Thus, owing to above mentioned factors it is expected that the market is likely to increase significantly during the forecast period.

Veeva Systems, IQVIA Inc., Ennov, AB Cube, United Biosource LLC, ArisGlobal LLC, Sparta Systems, Oracle Corporation, Sarjen Systems Pvt. Ltd, EXTEDO, Maxapplication, and Online Business Applications, Inc. are among the leading companies in the Europe pharmacovigilance and drug safety software market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in April 2020, Veeva Systems today unveiled Veeva Vault Signal, the industry's first solution that offers quick access to risk-based signal management through a single interface. Vault Signal unites all signal processing operations so scientists can handle safety signals with greater clarity through the entire workflow.

The report segments the Europe Pharmacovigilance and Drug Safety Software market as follows:

By Software Type
  • Fully Integrated Software
  • Adverse Event Reporting Software
  • Drug Safety Audits Software
  • Issue Tracking Software
By Delivery Mode
  • Cloud-based
  • On-premise
By End User
  • Contract Research Organizations
  • Pharmaceutical and Biotech Companies
  • Business Process Outsourcing
By Country
  • Europe - Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AB Cube
  • ArisGlobal LLC
  • Ennov
  • EXTEDO
  • IQVIA Inc.
  • Maxapplication
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 The Publisher's Research Report Guidance
1.3 Market Segmentation
1.3.1 Pharmacovigilance and Drug Safety Software Market - By Software Type
1.3.2 Pharmacovigilance and Drug Safety Software Market - By Delivery Mode
1.3.3 Pharmacovigilance and Drug Safety Software Market - By End User
1.3.4 Europe Pharmacovigilance and Drug Safety Software Market - By Country

2. Europe Pharmacovigilance and Drug Safety Software Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Pharmacovigilance and Drug Safety Software Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Pharmacovigilance and Drug Safety Software Market- Europe PEST Analysis
4.3 Expert Opinion

5. Europe Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Adverse Drug Reactions (ADRs)
5.1.2 Globalization of Pharmacovigilance
5.2 Market Restraints
5.2.1 Expensive Technology
5.3 Future Trends
5.3.1 Artificial Intelligence in Pharmacovigilance
5.4 Impact Analysis

6. Pharmacovigilance and Drug Safety Software Market - Europe Analysis
6.1 Europe Pharmacovigilance and Drug Safety Software Market Revenue Forecasts and Analysis

7. Europe Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts To 2027 - By Software Type
7.1 Overview
7.2 Pharmacovigilance (PV) and Drug Safety Software Market, by Software Type, 2019 & 2027 (%)
7.3 Adverse Event Reporting Software Market
7.3.1 Overview
7.3.2 Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Drug Safety Audits Software
7.4.1 Overview
7.4.2 Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Issue Tracking Software
7.5.1 Overview
7.5.2 Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Fully Integrated Software
7.6.1 Overview
7.6.2 Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)

8. Europe Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts To 2027 - By Delivery Mode
8.1 Overview
8.2 Pharmacovigilance (PV) and Drug Safety Software Market, By Delivery Mode 2019 & 2027 (%)
8.3 On-premise
8.3.1 Overview
8.3.2 On-premise Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Cloud- Based
8.4.1 Overview
8.4.2 Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)

9. Europe Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts to 2027- By End User
9.1 Overview
9.2 Pharmacovigilance (PV) and Drug Safety Software Market, By End User, 2019 & 2027 (%)
9.3 Pharmaceutical and Biotech Companies Market
9.3.1 Overview
9.3.2 Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Contract Research Organizations (CROs) Market
9.4.1 Overview
9.4.2 Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Business Process Outsourcing (BPO) Firms Market
9.5.1 Overview
9.5.2 Business Process Outsourcing (BPO) Firms Market Revenue and Forecasts to 2027 (US$ Mn)

10. Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 - Geographical Analysis
10.1 Europe: Pharmacovigilance and Drug Safety Software Market
10.1.1 Overview
10.1.2 Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
10.1.3 UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.3.1 UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.3.2 UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)
10.1.3.3 UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.1.3.4 UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User(US$ Mn)
10.1.4 Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027(US$ Mn)
10.1.4.1 Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.4.2 Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)
10.1.4.3 Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.1.4.4 Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.1.5 France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.5.1 France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.5.2 France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)
10.1.5.3 France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.1.5.4 France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.1.6 Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6.1 Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6.2 Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Software Type (US$ Mn)
10.1.6.3 Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Delivery Mode (US$ Mn)
10.1.6.4 Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.1.7 Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027(US$ Mn)
10.1.7.1 Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027(US$ Mn)
10.1.7.2 Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)
10.1.7.3 Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Delivery Mode (US$ Mn)
10.1.7.4 Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.1.8 Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.2 Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)
10.1.8.3 Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Delivery Mode (US$ Mn)
10.1.8.4 Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on Europe Pharmacovigilance and Drug Safety Software Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Pharmacovigilance and Drug Safety Software Market
12.3 Organic Developments
12.3.1 Overview
12.3.2 Organic Developments Done by Companies
12.4 Inorganic Developments
12.4.1 Overview
12.4.2 Inorganic Growth Strategies by Companies

13. Company Profiles
13.1 Veeva Systems
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 IQVIA Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Ennov
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 AB Cube
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 United Biosource LLC
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 ArisGlobal LLC
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sparta Systems
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Oracle Corporation
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Sarjen Systems Pvt. Ltd
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 EXTEDO
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Maxapplication
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Online Business Applications, Inc.
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments

14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms

List of Tables
Table 1. UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 2. UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 3. UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By End User (US$ Mn)
Table 4. Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 5. Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 6. Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 7. France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 8. France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 9. France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 10. Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Software Type(US$ Mn)
Table 11. Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 12. Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By End User (US$ Mn)
Table 13. Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Software Type(US$ Mn)
Table 14. Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Delivery Mode (US$ Mn)
Table 15. Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 16. Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 17. Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027,By Delivery Mode (US$ Mn)
Table 18. Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 19. Organic Developments Done by Companies
Table 20. Recent Inorganic Growth Strategies by the Companies
Table 21. Glossary of Terms, Pharmacovigilance and Drug Safety Software Market

List of Figures
Figure 1. Pharmacovigilance and Drug Safety Software Market Segmentation
Figure 2. Europe Pharmacovigilance and Drug Safety Software Market Overview
Figure 3. Adverse Event Reporting Software Segment Held Largest Share of Software Type in Pharmacovigilance and Drug Safety Software Market
Figure 4. Contract Research Organizations Segment Held Largest Share of End User in Pharmacovigilance and Drug Safety Software Market
Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Pharmacovigilance and Drug Safety Software Market - Europe PEST Analysis
Figure 7. Pharmacovigilance and Drug Safety Software Market Impact Analysis of Driver and Restraints
Figure 8. Europe Pharmacovigilance and Drug Safety Software Market - Revenue Forecasts and Analysis - 2019- 2027
Figure 9. Pharmacovigilance (PV) and Drug Safety Software Market, by Software Type, 2019 & 2027 (%)
Figure 10. Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Pharmacovigilance (PV) and Drug Safety Software Market, by Delivery Mode 2019 & 2027 (%)
Figure 15. On-premise Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Pharmacovigilance (PV) and Drug Safety Software Market, by End User, 2019 & 2027 (%)
Figure 18. Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Business Process Outsourcing (BPO) Firms Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Europe Pharmacovigilance and Drug Safety Software Market Revenue Overview, By Country, 2019(US$ Mn)
Figure 22. Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
Figure 23. UK Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Germany Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. France Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Italy Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Spain Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Impact of COVID-19 Pandemic in European Country Markets
Figure 30. Growth Strategies in the Pharmacovigilance and Drug Safety Software Market
Note: Product cover images may vary from those shown
  • Veeva Systems
  • IQVIA Inc.
  • Ennov
  • AB Cube
  • United Biosource LLC
  • ArisGlobal LLC
  • Sparta Systems
  • Oracle Corporation
  • Sarjen Systems Pvt. Ltd
  • EXTEDO
  • Online Business Applications, Inc.
  • Maxapplication
Note: Product cover images may vary from those shown
Adroll
adroll